SCHEMBL25323896

SCHEMBL25323896

Fc1ccc(-c2nn(CC(F)(F)F)cc2Br)nc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 5/20 0.35
MAPK14 Q16539 4/20 0.35
RIPK1 Q13546 1/20 0.32
TGFBR1 P36897 3/20 0.31
STK17B O94768 1/20 0.31
CSF1R P07333 1/20 0.31
IKBKE Q14164 1/20 0.31
AAK1 Q2M2I8 1/20 0.31
LRRK2 Q5S007 1/20 0.31
ULK3 Q6PHR2 1/20 0.31
NUAK2 Q9H093 1/20 0.31
MKNK2 Q9HBH9 1/20 0.31
PI4KB Q9UBF8 1/20 0.31
TBK1 Q9UHD2 1/20 0.31
TRPV3 Q8NET8 1/20 0.30
GRM5 P41594 1/20 0.30
GABRA5 P31644 1/20 0.30
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25321487 0.83 NPC1 (0.41) CSNK1DMAPK14TGFBR1TRPV3GRM5
SCHEMBL25324809 0.82 CSNK1D (0.39) CSNK1DMAPK14TGFBR1GRM5
SCHEMBL25323924 0.80 S1PR1 (0.36) CSNK1DMAPK14TGFBR1TRPV3
SCHEMBL25323601 0.76 ALDH1A2 (0.34) CSNK1DMAPK14TGFBR1
SCHEMBL25323855 0.75 CSNK1D (0.50) CSNK1DMAPK14TGFBR1
SCHEMBL25325346 0.74 CSNK1D (0.36) CSNK1DMAPK14TGFBR1TRPV3GRM5
SCHEMBL25323953 0.72 CSNK1D (0.38) CSNK1DMAPK14TGFBR1TRPV3GRM5
SCHEMBL30574243 0.72 ALOX5AP (0.42) LRRK2GRM5
SCHEMBL26113784 0.72 PDE10A (0.39) MAPK14
SCHEMBL30509482 0.71 CSNK1D (0.42) CSNK1DMAPK14TGFBR1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
EP-4214199-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-07-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS CSNK1D, CSNK1A1, CSNK2A1 CSNK1D 1/4885MAPK14 441/4885RIPK1 824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.